Search

When the Family Medicine for America's Health (FMAHealth) Workforce Education and Development Tactic Team (WEDTT) began its work in December 2014, one of its charges from the FMAHealth Board was to increase family physician production to achieve the diverse primary care workforce the United States needs. The WEDTT created a multilevel interfunctional team to work on this priority initiative that included a focus on student, resident, and early-career physician involvement and leadership development. One major outcome was the adoption of a shared aim, known as 25 x 2030. Through a collaboration of the WEDTT and the eight leading family medicine sponsoring organizations, the 25 x 2030 aim is to increase the percentage of US allopathic and osteopathic medical students choosing family medicine from 12% to 25% by the year 2030. The WEDTT developed a package of change ideas based on its theory of what will drive the achievement of 25 x 2030, which led to specific projects completed by the WEDTT and key collaborators. The WEDTT offered recommendations for the future based on its 3-year effort, including policy efforts to improve the social accountability of US medical schools, strategy centered around younger generations' desires rather than past experiences, active involvement by students and residents, engagement of early-career physicians as role models, focus on simultaneously building and diversifying the family medicine workforce, and security of the scope future family physicians want to practice. The 25 x 2030 initiative, carried forward by the family medicine organizations, will use collective impact to adopt a truly collaborative approach toward achieving this much needed goal for family medicine. [ABSTRACT FROM AUTHOR]

The article offers information about Genetic Information Nondiscrimination Act (GINA) in the U.S. A case of a 39-year-old woman with an invasive breast cancer was presented to illustrate the concept of a diagnosed genetic condition in a patient and a family member's increased risk of developing the condition and how GINA protect patients and their families. It explains the coverage of GINA which specifically defines genetic information and the intersection of GINA and health care reform.

Rosacea is a common chronic, and sometimes progressive, dermatosis. It is characterized, alone or in combination, by central facial erythema, symmetric flushing, stinging sensation, inflammatory lesions (papules and pustules), telangiectasias, and phymatous changes (tissue hyperplasia and nodules). Rosacea can occur in adults of any ethnicity, and adversely affects patients' quality of life. The condition can be effectively controlled with therapy tailored to the specific subtype of rosacea that is affecting the patient. Topical metronidazole, sulfacetamide/sulfur, and azelaic acid are generally effective for patients with mild rosacea. For moderate papulopustular rosacea, combination therapy with oral tetracyclines and topical agents is the first-line choice. Treatment with a topical agent, such as metronidazole, may help maintain remission. Patients with ocular involvement may benefit from long-term oral antibiotics and metronidazole gel. Referral to a subspecialist is necessary for patients who have ocular rosacea with ophthalmic complications, severe or recalcitrant rosacea, or phymatous changes. [ABSTRACT FROM AUTHOR]

The article discusses the authors' view regarding the paper that presents the 26 genes identified by the Tumor Sequencing Project (TSP). The authors relate that the article demonstrates how genetics will influence the clinical practice of the physician assistants (PA) and will become the fundamental science for health care providers. The authors state that they aim to present practical applications of genetics and show the clinical relevance of genetics to different disciplines in the PA.

An estimated 30% of members of the American College of Mohs Surgery (ACMS) are using physician assistants (PAs).' In Mohs surgery, the surgeon and the pathologist are the same person,2 so understanding which tasks are being delegated to PAs working in Mohs surgery is important. Our survey explores the number of PAs working with Mohs surgeons and the tasks delegated to PAs in this specialty. [ABSTRACT FROM AUTHOR]

An estimated 30% of members of the American College of Mohs Surgery (ACMS) are using physician assistants (PAs). In Mohs surgery, the surgeon and the pathologist are the same person, so understanding which tasks are being delegated to PAs working in Mohs surgery is important. Our survey explores the number of PAs working with Mohs surgeons and the tasks delegated to PAs in this specialty.